Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 3000 Lakeside Dr, Suite 300N BANNOCKBURN IL 60015 |
Tel: | 1-312-9402538 |
Website: | https://optioncarehealth.com |
IR: | See website |
Key People | ||
John Charles Rademacher President, Chief Executive Officer, Director | Michael H. Shapiro Chief Financial Officer | Luke Whitworth Chief Operating Officer |
Michael Bavaro Chief Human Resource Officer, Chief Diversity Officer | Collin G. Smyser General Counsel, Corporate Secretary |
Business Overview |
Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company's infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Company's home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient's condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement. |
Financial Overview |
For the three months ended 31 March 2024, Option Care Health Inc revenues increased 13% to $1.15B. Net income increased 14% to $44.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Total other expense decrease of 5% to $13.2M (expense), Other, net increase of 100% to $2K (income). |
Employees: | 5,809 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $6,045M as of Mar 31, 2024 |
Annual revenue (TTM): | $4,433M as of Mar 31, 2024 |
EBITDA (TTM): | $379.28M as of Mar 31, 2024 |
Net annual income (TTM): | $272.67M as of Mar 31, 2024 |
Free cash flow (TTM): | $170.83M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $842.77M as of Mar 31, 2024 |
Shares outstanding: | 173,816,267 as of Apr 19, 2024 |
Index Membership: | S&P 400 Mid Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |